Tag:

Pfizer

Roche shares fall after breast cancer drug fails trial

Shares in Roche dropped more than 5% on March 9 after the Swiss pharmaceutical company announced that its experimental oral breast cancer drug giredestrant failed to show effectiveness in newly diagnosed patients.

09 Mar 2026-13:54
Pfizer bets on China’s GLP-1 drug market

Pfizer has signed a licensing agreement with China-based Sciwind Biosciences for its type 2 diabetes treatment ecnoglutide, in a deal that could generate up to $495 million in milestone payments.

24 Feb 2026-10:18
Pfizer shares slip despite Q4 earnings beat

Shares of Pfizer edged lower in premarket trading on Tuesday, even after the drugmaker reported fourth-quarter earnings and revenue that exceeded Wall Street expectations.

03 Feb 2026-16:51
Novartis, Roche back US push to cut prescription drug costs

Swiss pharmaceutical giants Novartis and Roche have expressed support for U.S. efforts to lower drug prices and are working with the Trump administration on potential pricing agreements. The discussions follow a trend of recent deals by Pfizer, AstraZeneca, Eli Lilly, and Novo Nordisk to reduce costs for Medicare, Medicaid, and cash-paying patients.

18 Dec 2025-13:35
Metsera shares drop after Novo Nordisk ends bid, Pfizer wins acquisition

Metsera Inc. shares saw a significant drop of up to 16% in premarket trading, following news that Novo Nordisk A/S would not raise its offer further in the face of competition from Pfizer Inc.

10 Nov 2025-17:06
Novo Nordisk shares rise after dropping Metsera bid

Shares of Danish pharmaceutical giant Novo Nordisk rose in early trade on Monday after the company abandoned its bid for U.S. weight-loss drug developer Metsera. The move ends a bidding contest with Pfizer, which secured the deal for $10 billion.

10 Nov 2025-12:47
Novo Nordisk CEO faces high-stakes debut as board overhaul, Pfizer clash shake company

Novo Nordisk’s new CEO Mike Doustdar will make his first major public test this week as the drugmaker prepares to unveil third-quarter earnings amid a deep leadership shakeup, aggressive restructuring, and an escalating fight with U.S. rival Pfizer.

04 Nov 2025-10:20
Trump set to unveil US drug pricing deal at the White House

President Donald Trump is expected to announce on Friday a plan to lower U.S. drug prices, according to a White House official, though they declined to provide further details.

10 Oct 2025-21:29
Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers

01 Oct 2025-17:22
Pfizer to acquire Metsera in $4.9 billion deal

Pfizer (PFE) announced on Monday that it will acquire weight-loss drug developer Metsera (MTSR) in a deal valued at up to $4.9 billion, aiming to strengthen its foothold in the rapidly growing obesity treatment market.

22 Sep 2025-15:47